Search

Your search keyword '"Dutta, L."' showing total 166 results

Search Constraints

Start Over You searched for: Author "Dutta, L." Remove constraint Author: "Dutta, L."
166 results on '"Dutta, L."'

Search Results

1. Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆

2. Effect of Nano Zinc Supplementation on Reproductive Performance of Assam Hill Goat.

3. Induction of Postpartum Oestrus in Lakhimi Cows through Hormonal and Nutritional Interventions.

4. Nonlinear Offset Measurement and Nullification for Effective Resistive Sensor Design

5. EXCESS workshop: Descriptions of rising low-energy spectra

7. 401P A phase Ib study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients (pts) with advanced solid tumors

10. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

12. O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors

13. 145 Characterization of adverse reactions in patients with advanced endometrial cancer (aec) receiving lenvatinib + pembrolizumab (Study 309/KEYNOTE-775)

14. 726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)

15. 796P Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111

16. Post hoc analysis of the CLEAR study in advanced renal cell carcinoma (RCC) : Effect of subsequent therapy on survival outcomes in the lenvatinib (L) plus everolimus (E) vs sunitinib (S) treatment arms

17. Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

18. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study

19. 323 ENGOT-en9/LEAP-001: a phase 3 study of first-line pembrolizumab plus lenvatinib compared with chemotherapy in advanced or recurrent endometrial cancer

20. 443TiP A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents, and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082)

21. ENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial cancer

22. 1668TiP A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082)

25. ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

27. Identification and clinico-gynaecological characterization of reproductive disorders in crossbred cows under field conditions.

34. EFFICACY OF DIFFERENT TAPIOCA VARIETIES ON LARVAL GROWTH AND QUANTITATIVE COCOON CHARACTERS OF ERI SILKWORM, SAMIA RICINI BOISD.

35. EXTENT OF ADOPTION OF SCIENTIFIC ERI CULTURE PRACTICES BY THE REARERS IN JORHAT DISTRICT OF ASSAM.

37. Study of fungus keratitis

40. INCIDENCE AND INTENSITY OF ATTACK OF ARIADNE MERIONE C. INFESTING CASTOR - A PRIMARY FOOD PLANT OF ERI SILKWORM IN THE AGRO-ECOSYSTEM OF ASSAM.

41. EFFECT OF OVIPOSITION DEVICES AND MATING DURATIONS ON OVIPOSITION, FECUNDITY AND HATCHABILITY OF MUGA SILKWORM, ANTHERAEA ASSAMA WW.

46. Congenital glaucoma

48. CELL PROLIFERATION IN COMPENSATORY RENAL GROWTH1.

Catalog

Books, media, physical & digital resources